These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10943316)

  • 1. Application of T cell immunotherapy for human viral and malignant diseases.
    Riddell SR; Warren EH; Lewinsohn D; Mutimer H; Topp M; Cooper L; de Fries R; Greenberg PD
    Ernst Schering Res Found Workshop; 2000; (30):53-73. PubMed ID: 10943316
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic modification of T-cell clones for therapy of human viral and malignant diseases.
    Greenberg PD; Finch RJ; Gavin MA; Kalos M; Lewinsohn DA; Lonergan M; Lord JD; Nelson BH; Ohlén C; Sing AP; Warren EH; Yee C; Riddell SR
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S100-5. PubMed ID: 9619278
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones.
    Riddell SR; Greenberg PD
    Curr Top Microbiol Immunol; 1994; 189():9-34. PubMed ID: 7924439
    [No Abstract]   [Full Text] [Related]  

  • 4. Principles for adoptive T cell therapy of human viral diseases.
    Riddell SR; Greenberg PD
    Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular adoptive immunotherapy after bone marrow transplantation.
    Riddell SR; Greenberg PD
    Cancer Treat Res; 1995; 76():337-69. PubMed ID: 7577343
    [No Abstract]   [Full Text] [Related]  

  • 6. Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation.
    Warren EH; Gavin M; Greenberg PD; Riddell SR
    Curr Opin Hematol; 1998 Nov; 5(6):429-33. PubMed ID: 9814651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
    Lemmermann NA; Reddehase MJ
    Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of immunotherapy.
    Moss P
    Vox Sang; 2004 Jul; 87 Suppl1():26-9. PubMed ID: 15200599
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.
    Slobod KS; Benaim E; Woodruff L; Nooner S; Houston J; Holladay M; Lockey T; Hurwitz JL
    Immunol Res; 2001; 24(3):289-301. PubMed ID: 11817326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Leu-7-positive T lymphocytes during cytomegalovirus infection following allogeneic bone marrow transplantation for hematologic malignancies.
    Forman SJ; Zaia JA; Wright C; Gallagher MT; Blume KG
    Transplantation; 1986 Feb; 41(2):268-71. PubMed ID: 3003978
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular immunotherapy for viral infection after HSC transplantation.
    Moss P; Rickinson A
    Nat Rev Immunol; 2005 Jan; 5(1):9-20. PubMed ID: 15630425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferred immune cells may help fight viral infection.
    Hoffman M
    Science; 1992 Jul; 257(5067):166. PubMed ID: 1321492
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones.
    Riddell SR; Warren EH; Gavin MA; Akatsuka Y; Lewinsohn D; Mutimer H; Cooper L; Topp MS; Bonini C; Greenberg PD
    Cancer J; 2000 May; 6 Suppl 3():S250-8. PubMed ID: 10874495
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive immunotherapy of human cytomegalovirus infection: potential role in protection from disease progression.
    Greenberg P; Goodrich J; Riddell S
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):97-101. PubMed ID: 1648844
    [No Abstract]   [Full Text] [Related]  

  • 15. Adoptive cancer immunotherapy: discovering the best targets.
    Perreault C; Brochu S
    J Mol Med (Berl); 2002 Apr; 80(4):212-8. PubMed ID: 11976730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMV-specific immunotherapy.
    Einsele H; Hebart H
    Hum Immunol; 2004 May; 65(5):558-64. PubMed ID: 15172457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell therapy of cytomegalovirus and human immunodeficiency virus infection.
    Riddell SR; Greenberg PD
    J Antimicrob Chemother; 2000 Apr; 45 Suppl T3():35-43. PubMed ID: 10855770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunotherapy for cytomegalovirus and HIV-1 infection.
    Van den Bosch GA; Ponsaerts P; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(2):107-21. PubMed ID: 16531812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.
    Riddell SR; Walter BA; Gilbert MJ; Greenberg PD
    Bone Marrow Transplant; 1994; 14 Suppl 4():S78-84. PubMed ID: 7728132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy following allogeneic bone marrow transplantation.
    Dazzi F; Goldman JM
    Annu Rev Med; 1998; 49():329-40. PubMed ID: 9509267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.